Practical considerations for the integration of subcutaneous targeted therapies into the oncology clinic
<p class="p1">The oncology clinic is changing, with an increasing number of cancer therapies becoming available as formulations for subcutaneous (SC) injection. Using targeted therapies, such as alemtuzumab, bortezomib, rituximab or trastuzumab, via SC injection can be advantageous f...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pappin Communications
2019-10-01
|
| Series: | Canadian Oncology Nursing Journal |
| Online Access: | https://canadianoncologynursingjournal.com/index.php/conj/article/view/1020 |